Gordonia polyisoprenivorans septicemia in a bone marrow transplant patient.
Kempf
V A J
VA
Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Eberhard-Karls-Universität, Elfriede-Aulhorn Strasse 6, 72076 Tübingen, Germany. volkhard.kempf@med.uni-tuebingen.de
Schmalzing
M
M
Yassin
A F
AF
Schaal
K P
KP
Baumeister
D
D
Arenskötter
M
M
Steinbüchel
A
A
Autenrieth
I B
IB
D000193:Actinomycetales Infections / Q000175:diagnosis* / Q000188:drug therapy; D000328:Adult; D000900:Anti-Bacterial Agents; D001483:Base Sequence; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000276:immunology*; D004269:DNA, Bacterial / Q000032:analysis; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D033601:Gordonia Bacterium / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000601:surgery; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D018570:Risk Assessment; D018805:Sepsis / Q000175:diagnosis* / Q000188:drug therapy; D012720:Severity of Illness Index; D014184:Transplantation, Homologous / Q000009:adverse effects; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial